Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
M

Safety and Efficacy of Acalabrutinib + Bendamustine / Rituximab in Patients with Treatment-Naive or R/R MCL

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Michael Wang
By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Michael Wang
213 views
October 18, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Mantle Cell Lymphoma
12:35

2019 Frontline Therapy for Mantle Cell Lymphoma: Cytarabine as a Key…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

S. Rule

32 views
15:27

Novel Salvage Therapy in Mantle Cell Lymphoma: Discussion on Agents …

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

S. Rule

323 views
15:47

Who Is a Candidate for Watch and Wait Therapy in MCL / What Are the …

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

A. Kumar

22 views
11:48

Safety and Efficacy of Acalabrutinib + Bendamustine / Rituximab in P…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

M. Wang

213 views